NFE2L2 and lung cancer: Similarly, Takahashi et al. showed that 3D CRISPR screens more effectively reveal the molecular pathogenesis mediated by nuclear factor erythroid 2-related factor 2 (NRF2) hyperactivation in lung cancer compared to their 2D counterparts.(Takahashi et al., 2020).